Buy Tesamorelin Europe
Buy Tesamorelin Europe. Modified GHRH analogue for lipodystrophy and metabolic research. ≥99% purity. Fast EU delivery.
What is Tesamorelin?
Tesamorelin (TH9507) is a synthetic 44-amino acid analogue of human growth hormone releasing hormone (GHRH) with a trans-3-hexenoic acid modification at the N-terminus. This modification enhances enzymatic resistance and increases potency compared to native GHRH. For published research, see PubMed studies on Tesamorelin{:target=“_blank” rel=“noopener”}.
Tesamorelin is unique among GHRH analogues for its extensive clinical data on visceral adipose tissue reduction, making it particularly valuable for metabolic and lipodystrophy research.
Best-Peptides supplies research-grade Tesamorelin with guaranteed ≥99% purity.
How Does Tesamorelin Work?
GHRH Receptor Activation
- Enhanced GHRH-R binding - Modified N-terminus
- GH synthesis - Increased gene transcription
- GH release - Stimulated secretion
- IGF-1 elevation - Downstream effects
Metabolic Effects
- Visceral fat reduction - Selective adipose targeting
- Lipid metabolism - Triglyceride reduction
- Insulin sensitivity - Metabolic improvement
- Body composition - Lean mass preservation
Enhanced Stability
- Trans-3-hexenoic acid - N-terminal modification
- Enzymatic resistance - Reduced DPP-IV degradation
- Improved potency - Enhanced receptor engagement
- Extended activity - Compared to native GHRH
Research Applications
Metabolic Research
- Visceral adiposity - Fat reduction studies
- Lipodystrophy models - Drug-induced and metabolic
- Metabolic syndrome - Multi-factor studies
Endocrine Research
- GHRH receptor pharmacology - Modified agonist studies
- GH axis regulation - Feedback mechanisms
- Comparative GHRH studies - Analogue comparison
Body Composition
- Visceral vs subcutaneous fat - Selective effects
- Lean mass - Preservation studies
- Lipid profiles - Metabolic markers
Tesamorelin Specifications
| Specification | Detail |
|---|---|
| CAS Number | 218949-48-5 |
| Molecular Formula | C₂₂₁H₃₆₆N₇₂O₆₇S |
| Molecular Weight | 5135.9 g/mol |
| Sequence | Trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH₂ |
| Purity | ≥99% (HPLC) |
| Appearance | White lyophilised powder |
Storage and Handling
| Condition | Temperature | Duration |
|---|---|---|
| Lyophilised | -20°C | Up to 24 months |
| Reconstituted | 2-8°C | Up to 4 weeks |
Ordering Information
| Size | Price |
|---|---|
| 2 mg | From €35 |
| 10 mg | From €85 |
Minimum order: €200 | 10% discount on orders over €200
Research Use Statement
For laboratory research only. Not intended for human or veterinary use. Researchers should follow all applicable regulations.
Specifications
| CAS No. | 218949-48-5 |
|---|---|
| Molecular Weight | 5135.9 g/mol |
| Purity | ≥ 99% |
| Storage | -20°C recommended (research-only) |
| Available Sizes | 10 × 2 mg vials |
| Price Range | €350 per pack |
FAQ
Tesamorelin is studied for GH release, visceral adipose tissue reduction, lipodystrophy models, and metabolic syndrome research. It's the only GHRH analogue studied for visceral fat reduction.
Tesamorelin is a 44-amino acid GHRH analogue with a trans-3-hexenoic acid modification at the N-terminus, giving it greater stability and potency than Sermorelin (GRF 1-29).
Tesamorelin activates GHRH receptors on pituitary somatotropes, stimulating GH release. The trans-3-hexenoic acid modification enhances enzymatic resistance and receptor affinity.
Store lyophilised Tesamorelin at -20°C. Once reconstituted, keep at 2-8°C and use within 4 weeks.
Our Tesamorelin is ≥99% pure as verified by HPLC. Each batch includes a Certificate of Analysis.
Clinical research has shown Tesamorelin significantly reduces visceral adipose tissue without affecting subcutaneous fat, making it valuable for metabolic research.
Reconstitute in sterile bacteriostatic water. Add solvent slowly and gently swirl to dissolve.
Tesamorelin is available in 2mg and 10mg vials.
Customer Reviews (12)
Based on 12 reviews
Dr. Martin Schneider • 2026-01-27Verified Purchase
Our visceral adiposity studies require quality Tesamorelin. Best-Peptides delivers consistently. GH release profiles match literature data.
Amsterdam Metabolic Lab • 2025-10-07Verified Purchase
Tesamorelin quality is exceptional. GHRH receptor activation robust and reproducible.
Dr. Cécile Bernard • 2026-03-08Verified Purchase
Fast delivery, excellent quality. Lipodystrophy research progressing well.
Munich Endocrine Research • 2025-10-02Verified Purchase
Consistent quality for our GHRH analogue comparison studies.
Dr. Dimitri Stavros • 2025-10-13Verified Purchase
Verified purity exceeds claims. Essential for our metabolic syndrome models.
Lyon Adipose Research • 2026-01-08Verified Purchase
Fast delivery, great quality. Visceral fat reduction studies showing clear effects.
Katharina Fischer • 2026-02-19Verified Purchase
Express delivery to Austria within 2 days. Quality excellent.
Geneva Metabolic Lab • 2026-01-05Verified Purchase
Quality excellent. GH release kinetics show expected results.
Dr. João Pereira • 2025-12-25Verified Purchase
Excellent for endocrine research. Quality and documentation meet our standards.
Brussels Metabolic Studies • 2026-01-09Verified Purchase
Multiple orders, consistently excellent. Our preferred Tesamorelin source.
Peter van Dijk • 2026-02-09Verified Purchase
Easy ordering, quick delivery. Quality exactly as described.
Bratislava Peptide Lab • 2025-12-27Verified Purchase
High-quality Tesamorelin with proper documentation. Highly recommended.
Certificate of Analysis
Independent third-party lab test results for Tesamorelin Europe
COA: Tesamorelin Europe — best-Peptides.net
Related Products
View Complete Catalog
